Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Echo Therapeutics Inc    ECTE

Delayed Quote. Delayed  - 05/26 03:39:59 pm
1.64 USD   --.--%
05/19 INVESTIGATION F : ECTE) over Possible Violations of Securities Laws
05/17 ECHO THERAPEUTI : Announces Final Closing of Private Placement of $5..
04/26 ECHO THERAPEUTI : Announces Voting Results of Special Meeting of Sto..
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Investigation for Investors in Echo Therapeutics Inc (NASDAQ:ECTE) over Possible Violations of Securities Laws

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/19/2016 | 07:16pm CEST

An investigation for investors in Echo Therapeutics Inc (NASDAQ:ECTE) shares over potential securities laws violations by Echo Therapeutics Inc was announced and NASDAQ:ECTE stockholders should contact the Shareholders Foundation.San Diego, CA -- (SBWIRE) -- 05/19/2016 -- An investigation was announced for investors of Echo Therapeutics Inc (NASDAQ:ECTE) shares over potential securities laws violations in connection certain financial statements.

Investors who purchased shares of Echo Therapeutics Inc (NASDAQ:ECTE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on whether a series of statements regarding Echo Therapeutics' business, its prospects and its operations were materially false and misleading at the time they were made.

Iselin, NJ based Echo Therapeutics, Inc. is engaged in developing a non-invasive, wireless continuous glucose monitoring system with use in the wearable-health consumer market and the diabetes outpatient market. Echo Therapeutics Inc reported that its annual Net Loss increased from $14.96 million in 2014 to $22.20 million in 2015.

Shares of Echo Therapeutics Inc (NASDAQ:ECTE) closed at May 18, 2016, at $1.61 per share.

Those who purchased shares of Echo Therapeutics Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.comFor more information on this press release visit: http://www.sbwire.com/press-releases/investigation-investors-echo-therapeutics-inc-nasdaqecte-possible-violations-690586.htm

Media Relations Contact

Michael Daniels
General Manager
Shareholders Foundation
Telephone: 858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com

© ReleaseWire, source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on ECHO THERAPEUTICS INC
05/19 INVESTIGATION FOR INVESTORS IN ECHO : ECTE) over Possible Violations of Securit..
05/17 ECHO THERAPEUTICS : Announces Final Closing of Private Placement of $5.1 Million..
05/12 ECHO THERAPEUTICS : Announces Final Closing of Private Placement of $5.1 Million..
05/12 ECHO THERAPEUTICS : Announces Significant Progress in Key Development Milestones
05/04 ECHO THERAPEUTICS, INC. : Creation of a Direct Financial Obligation or an Obliga..
04/26 ECHO THERAPEUTICS : Announces Voting Results of Special Meeting of Stockholders
04/19 ECHO THERAPEUTICS : Creation of a Direct Financial Obligation or an Obligation u..
04/14 ECHO THERAPEUTICS : Submission of Matters to a Vote of Security Holders (form 8-..
04/06 ECHO THERAPEUTICS : Creation of a Direct Financial Obligation or an Obligation u..
03/22 ECHO THERAPEUTICS : Creation of a Direct Financial Obligation or an Obligation u..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials